Compounds > 5-hydroxy-1-methyl-2-(di-n-propylamino)tetralin
Page last updated: 2024-09-03

5-hydroxy-1-methyl-2-(di-n-propylamino)tetralin and n-n-propylnorapomorphine

5-hydroxy-1-methyl-2-(di-n-propylamino)tetralin has been researched along with n-n-propylnorapomorphine in 1 studies

Compound Research Comparison

Studies
(5-hydroxy-1-methyl-2-(di-n-propylamino)tetralin)		Trials
(5-hydroxy-1-methyl-2-(di-n-propylamino)tetralin)		Recent Studies (post-2010)
(5-hydroxy-1-methyl-2-(di-n-propylamino)tetralin)		Studies
(n-n-propylnorapomorphine)		Trials
(n-n-propylnorapomorphine)		Recent Studies (post-2010) (n-n-propylnorapomorphine)
500274412

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baldessarini, RJ; Froimowitz, M; Neumeyer, JL1

Other Studies

1 other study(ies) available for 5-hydroxy-1-methyl-2-(di-n-propylamino)tetralin and n-n-propylnorapomorphine

ArticleYear
A stereochemical explanation of the dopamine agonist and antagonist activity of stereoisomeric pairs.
    Journal of medicinal chemistry, 1986, Volume: 29, Issue:9

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Apomorphine; Chemical Phenomena; Chemistry; Dopamine; Dopamine Antagonists; Molecular Conformation; Naphthalenes; Piperidines; Receptors, Dopamine; Stereoisomerism; Structure-Activity Relationship; Tetrahydronaphthalenes; Thermodynamics

1986